Skip to content

Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver Surgery

Ultrasound-guided Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament Versus Thoracic Epidural Analgesia After Open Liver Surgery: A Prospective, Randomized, Controlled, Noninferiority Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04668391
Enrollment
74
Registered
2020-12-16
Start date
2020-12-17
Completion date
2021-07-02
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Surgery

Brief summary

This is a prospective, randomized, controlled, noninferiority trial for evaluating the efficacy of ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament versus thoracic epidural analgesia after open liver surgery.

Interventions

PROCEDUREUltrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament

Bilateral single-injection 20 ml 0.56% ropivacaine. Intravenous analgesia was started postoperatively and consisted of 1ug/ml sufentanil,2 ml/h with a 5-minute lockout period, a limited 12 ml/h dose.

PROCEDUREThoracic epidural analgesia

A thoracic epidural at the level of T7-10. Epidural infusion was started postoperatively and consisted of sufentanil (0.6ug/mL) and ropivacaine(0.2%) at 3ml/h.

Sponsors

Zhejiang Cancer Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age≥18 years * ASA I-III * Open liver surgery

Exclusion criteria

* Contraindication to nerve block or epidural puncture * Chronic use of opioids or NSAIDs * Refused to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
NRS (numeric rating scale) score for coughing painat 24 hours after surgeryPostoperative pain was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain)

Secondary

MeasureTime frameDescription
consumption of opioid converted to IV morphine equivalentsduring 24 hours after surgeryopioids given postoperatively converted to IV morphine equivalents
Numbers of additional analgesicsduring 72 hours after surgeryAdditional rescue analgesics were used when pain relief was inadequate (NRS \>3). The choice of rescue analgesic was oxydone 5-10mg.
The incidence of postoperative hypotensionduring 72 hours after surgeryAdverse reactions related to analgesia
The incidence of nausea and vomitingduring 72 hours after surgeryAdverse reactions related to analgesia
The incidence of pruritusduring 72 hours after surgeryAdverse reactions related to analgesia
The incidence of respiratory depressionduring 72 hours after surgeryAdverse reactions related to analgesia
NRS score for rest and coughing painat 1, 6, 24, 48, 72 hours after surgeryPostoperative pain at rest and during coughing was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain)
Time to eat in daysthrough study completion, an average of 2-3 daysTime to start eating after surgery
Time to flatus in hoursthrough study completion, an average of 40-50 hoursTime to flatus after surgery
Time to defecation in hoursthrough study completion, an average of 60-70 hoursTime to defecation after surgery
Time to urethral catheter removal in hoursthrough study completion, an average of 60-70 hoursTime tourethral catheter removal after surgery
Postoperative hospital stay in daysthrough study completion, an average of 7-8 daysThe time from operation to discharge
Clavien-Dindo classification (grade I, II, III, IV) for postoperative complicationOne month after surgeryPostoperative Clavien-Dindo complication classification
Time to ambulation in daysthrough study completion, an average of 2-3 daysPostoperative ambulation time

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026